SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR S&P 500 ETF TRUST - Units of undivided interest in SPDR Trust Series 1

SPY is experiencing significant volatility driven by reports of potential diplomatic shifts regarding the Iran conflict, sparking intense debate among traders over whether these developments signal a genuine de-escalation or just another short-term market manipulation. Community sentiment remains deeply polarized, with many market participants expressing skepticism toward overnight price action and warning of a potential 'pump and dump' as concerns persist over energy supply chains and the geopolitical implications of the Strait of Hormuz remaining closed.

Invesco QQQ Trust Series 1 - Units of beneficial interest

QQQ is experiencing intense volatility as investors react to the escalating geopolitical conflict in the Middle East and reports suggesting a shift in U.S. military objectives. Market participants are actively debating the potential for a snapback rally versus further downside, with sentiment heavily influenced by concerns over oil prices and skepticism regarding official statements.

Spdr Dow Jones Industrial Average ETF Trust - Units of undivided interest in DIAMONDS Trust Series 1

The SPDR Dow Jones Industrial Average ETF (DIA) is experiencing heightened volatility as market participants weigh geopolitical instability in the Middle East against conflicting reports regarding ceasefire negotiations. Investors are actively debating whether recent diplomatic updates signal a breakthrough or if systemic inflation and energy supply risks will continue to pressure the broader index.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

The United States Oil Fund is trending as investors grapple with escalating Middle East tensions, particularly reports of retaliatory strikes on energy infrastructure and ongoing debate regarding the impact of the Strait of Hormuz closure on global supply. The community remains deeply divided, with many traders actively discussing whether diplomatic updates are genuine market-moving news or merely tactical maneuvering by administration officials to influence sentiment.

iShares Trust - iShares Russell 2000 ETF

iShares Russell 2000 ETF

The Russell 2000 ETF is currently experiencing heightened volatility and intense option activity as market participants navigate shifting geopolitical narratives regarding potential ceasefire negotiations and military deployments in the Middle East. Community sentiment remains deeply divided, with traders closely monitoring the index's ability to maintain support levels at the 200-day moving average while debating whether recent price action represents a genuine bottoming process or a temporary relief rally fueled by institutional manipulation.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is facing intense selling pressure as a combination of geopolitical tensions, investor skepticism regarding AI-driven demand, and broader tech sector weakness triggers a sharp drawdown. The community is actively debating whether this is an overblown reaction to algorithmic efficiency news or a necessary technical correction for a stock that experienced a rapid, cyclical-driven run-up.

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is seeing heightened volatility as investors weigh geopolitical tensions and oil price fluctuations against optimistic reports of supply constraints and rising CPU prices. The community remains divided, with many traders debating whether the stock is a long-term value play based on foundry fundamentals or a short-term trap prone to aggressive manipulation by algorithms.

Maul Coin

Maul Coin is trending as the community rallies behind the creator's mission to build an organic, transparent project that resists typical whale manipulation. Investors are actively discussing the coin's growth potential, coordinating to get it listed on charting platforms, and emphasizing a 'hold' strategy to achieve long-term appreciation.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidia is trending as investors grapple with a significant technical correction and heightened geopolitical uncertainty surrounding the conflict in the Middle East. While many market participants remain focused on long-term AI fundamentals and discounted valuation metrics, debate continues regarding whether aggressive institutional selling signals a local bottom or the start of a broader cyclical decline.

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Battalion Oil is currently a focal point for traders tracking the rapid escalation of geopolitical tensions in the Middle East and the resulting surge in global oil prices. The community is actively debating the potential for a massive short squeeze, driven by supply chain disruptions, reports of major energy infrastructure damage, and widespread skepticism regarding government-led diplomatic negotiations.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Plus Therapeutics (PSTV) Reports Break-Even Earnings for Q4

Plus (PSTV) delivered earnings and revenue surprises of +100.00% and +2.02%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Nektar Therapeutics (NKTR) Reports Q4 Loss, Tops Revenue Estimates

Nektar (NKTR) delivered earnings and revenue surprises of +35.47% and +128.59%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Guardian Pharmacy Services (GRDN) Surpasses Q4 Earnings and Revenue Estimates

Guardian Pharmacy (GRDN) delivered earnings and revenue surprises of +37.04% and +2.41%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Crinetics Pharmaceuticals, Inc. (CRNX) Reports Q4 Loss, Beats Revenue Estimates

CRINETICS PHARM (CRNX) delivered earnings and revenue surprises of +6.01% and +38.05%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

Plus Therapeutics, Inc. (NASDAQ:PSTV) Given Average Rating of "Moderate Buy" by Brokerages

Shares of Plus Therapeutics, Inc. (NASDAQ:PSTV - Get Free Report) have been assigned an average recommendation of "Moderate Buy" from the seven analysts that are presently covering the company...

Plus Therapeutics, Inc. (NASDAQ:PSTV) Receives Average Rating of "Moderate Buy" from Analysts

Shares of Plus Therapeutics, Inc. (NASDAQ:PSTV - Get Free Report) have been given an average recommendation of "Moderate Buy" by the seven brokerages that are presently covering the company...

Plus Therapeutics (NASDAQ:PSTV) Earns "Buy" Rating from D. Boral Capital

D. Boral Capital reissued a "buy" rating and issued a $5.00 price target on shares of Plus Therapeutics in a research report on Thursday...

Plus Therapeutics' (PSTV) Buy Rating Reiterated at D. Boral Capital

D. Boral Capital reaffirmed a "buy" rating and issued a $5.00 price objective on shares of Plus Therapeutics in a research report on Monday...

HC Wainwright Expects Weaker Earnings for Plus Therapeutics

Plus Therapeutics, Inc. (NASDAQ:PSTV - Free Report) - Research analysts at HC Wainwright reduced their FY2027 EPS estimates for shares of Plus Therapeutics in a report issued on Wednesday, November...

What is HC Wainwright's Estimate for PSTV Q1 Earnings?

Plus Therapeutics, Inc. (NASDAQ:PSTV - Free Report) - Equities research analysts at HC Wainwright issued their Q1 2026 earnings per share (EPS) estimates for Plus Therapeutics in a research note...

Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company. The firm focuses on the development of chemotherapeutics and radio therapeutics for rare cancers that address unmet medical and market needs. Its products include Rhenium NanoLiposome and DocePLUS. The company was founded by Ralph E. Holmes and Christopher J. Calhoun in July 1996 and is headquartered in Houston, TX.

Plus Therapeutics Inc

Patrick OShaughnessy - @patrick_oshag on X

Citrini - @Citrini7 on X

Bucco Capital - @buccocapital on X

Joe Weisenthal - @TheStalwart on X

The must-watch individual or show that brings entertainment to finance. This award celebrates the content you look forward to daily - bringing a sharp market edge to engaging discussions. 

Current Price	$0.2146
Prev Close	$0.23
Open	$0.2282
Dividend Yield	0.00%
50-Day Moving Average	$0.2676
Beta	1.42
Avg. Volume	6.52M
PE Ratio	-0.17

52-Week High	$1.22
52-Week Low	$0.1634
Market Capitalization	$39.46M
EPS (Annual)	-$0.2877
Price to Book	7.45
Revenue Per Employee	$186,178.57

PSTV
Plus Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PSTV News

PSTVPlus Therapeutics Inc